ClinicalTrialsFinder

Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer Clinical Trials in Singapore

1 recruitingSingapore, Singapore

Showing 1–1 of 1 trials

Recruiting
Phase 2

Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole

Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
National Cancer Centre, Singapore40 enrolled1 locationNCT05286437